- Simplicity, Versatility, Targeted Delivery
- We offer a versatile catheter system for use with both standard and developing therapeutic agents.
- RenovoRx was honored at TiEcon on May 18th, 2013 as one of the only three winning startups in the Life Sciences vertical.
RenovoRx is a medical device company headquartered in Silicon Valley, California.
We are developing solutions for targeted delivery of therapeutic and diagnostic agents
to selected sites in the peripheral vascular system.
RenovoCath™ Catheter System
We do catheters differently. This video shows the RenovoCath RC120 special features and the role these features play in delivering therapeutic agents to targeted regions.Read More!
In the News
RenovoCath™ RC120 Receives FDA 510(k) Clearance
Menlo Park, CA (October 30, 2014) – RenovoRx, a leading developer of innovative solutions for targeted delivery of fluids to selected sites in the vascular system, today announced the company has received FDA 510(k) clearance of its flagship product, the … Continue readingRead More
RenovoRx Patent Issued
Menlo Park, CA (October 28, 2014) – RenovoRx, a leading developer of innovative solutions for the isolation of blood flow and delivery of fluids to selected sites in the vascular system, today announced that the United States Patent and Trademark … Continue readingRead More
RenovoRx Board Names Shaun R. Bagai as CEO
RenovoRx Inc. today announces that its Board of Directors has appointed Shaun R. Bagai as Chief Executive Officer and member of the Board of Directors effective June 16, 2014.Read More
Optimized design for targeted balloon placement
Contact delivery of therapeutic agents